Organigram Reports Record Revenue in Q3 2026 Earnings Call
During Organigram's third-quarter fiscal year 2026 earnings call, CEO James Yamanaka highlighted a significant milestone as the company reported its highest quarterly net revenue and adjusted EBITDA to date. This achievement reflects contributions from Sanity Group for nearly an entire quarter, marking progress in diversification and international expansion. Yamanakan noted that Organigram now holds 11.1% of Canada's recreational cannabis market share following strategic adjustments made earlier in the year. The company has reduced its SKU count by approximately 10%, focusing on stronger brands with clearer consumer positioning to improve operational efficiency and brand durability. CFO Greg Guyatt is expected to provide further financial details, while Yamanaka emphasized that Organigram's strategy is beginning to yield improved results, setting the stage for higher margins and long-term profitability.
Topics: cannabis_industry financial_results organizational_growth